undamentalytics Newsletter

Wilensky Gail R: insider trades

Director at 2 companies we cover. No open-market purchases and 35 sales not made under a pre-set plan, reported from March 22, 2010 to July 28, 2021.

What happened after Wilensky Gail R’s sales?

After their sales, the shares moved +7.5% against the index over 12 months on average (a negative figure means selling was the right call); 34% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Wilensky Gail R: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 35 +1.1% +3.0% 43% 12 0.52 0.61 No reliable evidence
Sales, 12 months after the report 35 +7.5% +14.0% 34% 12 1.87 0.088 No reliable evidence
Sales, 12 months after the trade 35 +8.0% +12.7% 34% 12 1.48 0.17 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
UnitedHealth Group UNH —025March 22, 2010April 26, 2019
Quest Diagnostics DGX —010February 9, 2011July 28, 2021

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
July 28, 2021July 27, 2021 DGX Sale $1,702,463 −1.0%+3.7%+5.1%
November 27, 2020November 24, 2020 DGX Sale $770,108 −11.1%−5.5%−10.2%
November 27, 2019November 26, 2019 DGX Sale $857,360 +6.5%+1.6%+0.6%
April 26, 2019April 24, 2019 UNH Sale $571,700 +4.3%+24.3%+28.6%
March 15, 2019March 14, 2019 UNH Sale $742,446 −5.6%+6.6%+11.7%
February 25, 2019February 22, 2019 DGX Sale $702,240 +11.6%+15.5%+13.0%
November 29, 2018November 28, 2018 UNH Sale $1,645,089 −16.2%−14.8%−15.5%
September 13, 2018September 12, 2018 UNH Sale $1,512,203 +10.3%−16.4%−15.8%
July 19, 2018July 18, 2018 UNH Sale $778,989 +6.7%−7.0%−5.8%
January 22, 2018January 18, 2018 UNH Sale $1,400,614 +2.6%+15.2%+13.4%
November 30, 2017November 29, 2017 UNH Sale $1,250,588 −4.0%+20.4%+22.3%
September 7, 2017September 5, 2017 UNH Sale $1,117,144 +4.1%+14.1%+16.5%
June 6, 2017June 2, 2017 UNH Sale $990,225 +6.9%+21.9%+23.6%
February 24, 2017February 23, 2017 UNH Sale $861,882 +5.3%+24.7%+25.2%
November 21, 2016November 17, 2016 UNH Sale $822,003 −0.4%+20.8%+21.3%
June 13, 2016June 10, 2016 UNH Sale $768,900 −5.0%+14.7%+12.7%
March 15, 2016March 14, 2016 UNH Sale $674,844 +7.7%+19.7%+17.8%
February 17, 2016February 16, 2016 UNH Sale $972,420 +4.4%+16.9%+18.3%
June 15, 2015June 11, 2015 UNH Sale $2,453,161 +4.3%+14.0%+16.8%
February 5, 2015February 4, 2015 DGX Sale $578,720 −0.9%−3.2%−4.6%
January 26, 2015January 22, 2015 UNH Sale $2,288,288 +2.5%+9.1%+7.7%
August 27, 2014August 26, 2014 UNH Sale $884,000 +9.9%+36.4%+36.4%
February 19, 2014February 18, 2014 UNH Sale $1,562,033 +3.0%+38.8%+34.8%
February 19, 2014February 18, 2014 DGX Sale $1,588,100 +5.8%+21.4%+21.6%
May 3, 2013May 2, 2013 DGX Sale $572,000 −4.6%−19.8%−20.9%
April 23, 2013April 19, 2013 UNH Sale $2,576,400 +16.6%+11.0%+4.1%
August 16, 2012August 15, 2012 DGX Sale $1,184,800 −1.7%−18.0%−18.9%
June 20, 2012June 19, 2012 UNH Sale $658,022 −16.2%−11.4%−12.1%
June 7, 2012June 6, 2012 UNH Sale $1,250,122 −14.0%−12.4%−15.6%
February 17, 2012February 16, 2012 UNH Sale $599,074 +3.6%−13.9%−11.5%
January 30, 2012January 27, 2012 DGX Sale $1,767,900 −6.2%−16.3%−16.1%
June 13, 2011June 10, 2010 UNH Sale $1,596,000 +5.6%+14.3%+46.1%
February 9, 2011February 7, 2011 DGX Sale $1,171,400 −1.0%−1.8%−3.9%
November 8, 2010November 5, 2010 UNH Sale $1,100,700 +4.8%+19.2%+21.0%
March 22, 2010March 19, 2010 UNH Sale $171,100 −0.9%+18.5%+13.4%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Wilensky Gail R traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.